Evaluation of Low Concentration Dithiothreitol for Negating the Monoclonal Anti-CD38 Interference with Transfusion Compatibility Testing.
10.19746/j.cnki.issn.1009-2137.2022.04.035
- Author:
Jie SONG
1
;
Ying-Hui CHEN LI
1
;
Ai-Ping LIU
1
;
Shu-Ya WANG
1
;
Xian-Ping LYU
2
Author Information
1. Department of Blood Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
2. Department of Blood Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China .E-mail: lvxianping@126.com.
- Publication Type:Journal Article
- Keywords:
alloantibody;
antibody screening;
dithiothreitol;
monoclonal anti-CD38
- MeSH:
Antibodies, Monoclonal/pharmacology*;
Blood Grouping and Crossmatching;
Blood Transfusion;
Dithiothreitol/pharmacology*;
Erythrocytes;
Humans;
Isoantibodies/pharmacology*
- From:
Journal of Experimental Hematology
2022;30(4):1198-1202
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effectiveness and safety of low concentration dithiothreitol (DTT) in removing the interference of monoclonal anti-CD38 on transfusion compatibility testing, and develop a reasonable clinical transfusion strategy.
METHODS:The blood type, direct antiglobulin testing (DAT) and antibody screening were tested according to standard methods. Antibody screening cells and donor's red blood cells were treated by DTT 0.2, 0.1, 0.05, 0.02, 0.01 and 0.005 mol/L, and antibody screening and cross-matching of serums after monoclonal anti-CD38 treatment were performed by anti-human globulin card.
RESULTS:The 0.01 mol/L DTT at 37℃ for 30 minutes could remove the effect of monoclonal anti-CD38 on antibody screening and cross-matching, meanwhile retain their effectiveness in detecting anti-K, anti-LW, anti-JMH, anti-Lub, anti-e, anti-Dia and anti-Jka alloantibodies. All the 10 patients had no acute or delayed haemolytic transfusion reactions and their routine blood tests showed that the red blood cells transfusion was effective.
CONCLUSION:The 0.01 mol/L DTT is a safe and effective method for removing the interference of monoclonal anti-CD38 with transfusion compatibility testing, while retaining the ability to detect most alloantibodies.
